Pretreatment platelet to lymphocyte ratio is predictive of overall survival in metastatic pancreatic ductal adenocarcinoma

BACKGROUND: This study aimed to investigate whether the pretreatment platelet to lymphocyte ratio (PLR) is a significant prognostic factor in metastatic pancreatic ductal adenocarcinoma (PDAC). METHODS: A total of 134 histologically confirmed PDAC patients were included in our retrospective study. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wanwan, Chen, Yang, Wang, Xuelin, Shi, Yan, Dai, Guanghai, Li, Xiaorong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799088/
https://www.ncbi.nlm.nih.gov/pubmed/35116729
http://dx.doi.org/10.21037/tcr.2018.12.20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799088/
https://www.ncbi.nlm.nih.gov/pubmed/35116729
http://dx.doi.org/10.21037/tcr.2018.12.20

Ejemplares similares